PP
RCEL icon

PDT Partners’s Avita Medical RCEL Stock Holding History

PDT Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,135
Closed -$217K – 1077
2021
Q4 		$217K Sell
18,135
-4,087
-18% -$62.3K 0.02% 749
2021
Q3 		$394K Sell
22,222
-3,518
-14% -$66.4K 0.03% 527
2021
Q2 		$528K Buy
25,740
+5,963
+30% +$118K 0.03% 504
2021
Q1 		$392K Buy
+19,777
New +$460K 0.03% 546

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PDT Partners's RCEL Position: Q1 2022 in Review

PDT Partners sold out of Avita Medical (RCEL) in Q1 2022, closing a stake of 18,135 shares — an estimated $217K sold.

PDT Partners first reported a position in RCEL in Q1 2021 and held it in 4 quarters. The position peaked at $528K in Q2 2021. 69 funds tracked by Wall St. Rank hold RCEL as of Q1 2022.

  • PDT Partners reported no remaining Avita Medical position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 18,135 Avita Medical shares in Q1 2022, an estimated $217K.
  • PDT Partners first reported a position in Avita Medical in Q1 2021 and held it in 4 quarters.
  • PDT Partners's Avita Medical position peaked at $528K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Avita Medical as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.